Groups
RESEARCH GROUPS
Contact information
Maria Giner Soriano
Degree in Pharmacy at the Universitat de València (1999-2004), specialist in Hospital Pharmacy via FIR (Parc de Salut Mar de Barcelona, 2008-2012) and Doctor of Pharmacology from the Universitat Autònoma de Barcelona (Department of Pharmacology, Therapeutics and Toxicology, 2016) with the thesis ‘Effectiveness and safety of thromboembolic prevention in patients with non-valvular atrial fibrillation’, receiving the Extraordinary Doctorate Award for the 2015-16 academic year in 2019. Since 2012, she has been working as a Research Scientist in Pharmacoepidemiology at the IDIAPJGol Medicines Research Unit, a research group accredited by AGAUR in 2023, where she mainly conducts research studies on drug use, effectiveness and safety using the SIDIAP database: She has participated as a researcher in publicly funded projects and in projects in collaboration with other European databases promoted by the pharmaceutical industry and requested by the European Medicines Agency (EMA), some of which are included in the risk management plans for different medicines marketed in Europe. Since 2017, she has also been carrying out pharmacoepidemiology projects to support the CatSalut Pharmacotherapeutic Harmonisation Programme from the Technical Office of Pharmacoepidemiology, and since 2022, pharmacovigilance projects to support the Catalonia Pharmacovigilance Centre. Since 2019, she has been leading the participation of IDIAPJGol’s participation in the SIGMA Consortium, a network of European professionals who are experts in pharmacoepidemiology, responsible for providing scientific evidence on the use, effectiveness and safety of medicines, vaccines and medical devices, for example through the VAC4EU (Vaccine Monitoring Collaboration for Europe) platform for the pharmacovigilance of vaccines authorised for COVID-19. Since 2021, he has been part of the RICAPPS network (Research Network on Chronicity, Primary Care and Health Prevention and Promotion), together with various IDIAPJGol researchers and primary care professionals from the Catalan Health Institute. She has published several articles in indexed scientific journals on the use of drugs in different conditions, using data from the SIDIAP database of electronic medical records from primary care in Catalonia. She is currently a researcher in the R3a category (doctoral researcher with recognised experience and high impact) of the European Framework for Research Careers, and she is the principal investigator of a competitively funded project and one funded by the IMI. She co-supervises several doctoral theses. She has been teaching on the Master’s Degree in Digital Health at the Universitat Oberta de Catalunya since 2020.
Projects
-
A Drug Utilization Study to Evaluate the Effectiveness of Risk Minimization Measures (RMMs) for Abrocitinib in the EU Using Electronic Healthcare Data
Principal Investigator: Giner Soriano, Maria
Funding entity: (2024)
-
ALETHEIA: Feasibility Assessment
Funding entity: (2019 - 2019)
-
Antiseizure meDication Exposure and Pregnancy and neonaTal outcomes research (ADEPT) Use of antiepileptics, and feasibility of studies on the association between maternal and paternal exposure to antiepileptics and risk of adverse pregnancy, neonatal and child outcomes
Principal Investigator: Giner Soriano, Maria
Funding entity: (2024)
-
Assessing drug exposure during pregnancy and breastfeeding and its outcomes in the offspring through a database cohort study
Principal Investigator: Ainhoa Gómez Lumbreras
Funding entity: (2018 - 2022)
-
BEAMER "BEhavioral and Adherence Model for improving quality, health outcomes and cost-Effectiveness of healthcaRe"
Principal Investigator: Elísio Costa
Funding entity: (2021 - 2026)
-
Características sociodemográficas, clínicas y farmacológicas asociadas con el pronóstico en pacientes con infección por SARS-CoV-2.
Principal Investigator: Rosa Morros Pedrós
Funding entity: (2020 - 2023)
Recent publications
-
Giner-Soriano M, Carrasco-Ribelles LA, Fernández-García S, Castel Llobet J, Cereza García G, Morros R. Póster. Asociación entre las hemorragias mayores y el tratamiento con fármacos que interaccionan con los anticoagulantes. Estudio de casos y controles. XIII Jornadas Nacionales de Farmacovigilancia. 12/11/2024, Oviedo.
-
Monfà R, Giner-Soriano M, Fernández-García S, Vallano A, Vives R, Morros R. Póster. Characteristics, treatment and outcomes in a reduced ejection fraction patient cohort from SIDIAP database, Catalonia, Spain. XXXII Congreso Nacional Sociedad Española de Farmacología Clínica, Santiago de Compostela. 16/10/2024, Santiago de Compostela.
-
Monfà R, García-Sangenís A, Fernández-García S, Bonilla R, Morros R, Giner-Soriano M. Póster. Drug utilization study in a cohort of migraine patients from SIDIAP database, Catalonia, Spain. XXXII Congreso Nacional Sociedad Española de Farmacología Clínica. 16/10/2024, Santiago de Compostela.
-
Monfà R, García-Sangenís A, Fernández-García S, Bonilla R, Morros R, Giner-Soriano M. Póster. Drug utilization study in a cohort of migraine patients from SIDIAP database, Catalonia, Spain. XXXII Congreso Nacional Sociedad Española de Farmacología Clínica. 16/10/2024, Santiago de Compostela.
-
Munné-Barellas B, García-Egea A, Morros R, Vedia C, Giner-Soriano M, Medina-Perucha L. Póster. Experiences prescribing medicines, alternative treatments and vaccines among health professionals in Catalonia (Spain): A qualitative study. XXXII Congreso Nacional Sociedad Española de Farmacología Clínica. 16/10/2024, Santiago de Compostela.
-
Fernández-García S, Moragas Moreno A, Giner-Soriano M, Ouchi D, Morros R, Llor C. Póster. Cystitis in men in Primary Care, what factors influence the development of pyelonephritis?. 25th WONCA World Conference. 17/09/2025, Lisboa.
93 482 46 94
671 511 120
info@ricapps.es
